News

Discover how ALLG's AMLM28 ADAPT trial is transforming AML treatment.

Team ALLG runners tackled the Sydney Marathon to raise vital funds for blood cancer research.

Go Red4Research & help fund clinical trials that are shaping the future of blood cancer treatment.

ALLG recently launched its 2025 Research Report, highlighting advances in blood cancer treatments.

Read about the highlights from ALLG's May 2026 Scientific Meeting.

New Zealand blood cancer crisis recognised, report finds gaps & instigates an oversight group led by ALLG.

A daughter shares her mother's legacy & story, highlighting the impact of AML clinical trials.

ALLG's letter to the New Zealand's Prime Minister highlights delays, limiting critical access to clinical trials.

ALL09 SUBLIME delivers breakthrough for young adults with leukaemia.

ALLG’s celebrates clinical trial advancements on World Cancer Day 2026.

Putting patients at the centre of clinical trials with input from our Consumer Representative Panel.

Clinical trials matter because they are the critical link between discovery to new & better treatments.

ALLG is expanding clinical trial access to novel blood cancer therapies, ensuring patients benefit from innovative treatments no matter where they live.

The AMLM26 INTERCEPT trial is an innovative multi-arm platform design for early detection of AML.

Discover how the ALLG National Blood Cancer Registry collects data to advance treatments & improve outcomes.

Learn how the ALLG ECCR Program supports the next generation of clinical trial researchers.

ALLG members present oral and poster presentations at ASH 2025, highlighting key trial results in blood cancer research. Explore the findings that are shaping the future of haematology.

CEO Delaine Smith, advocates at a MRFF roundtable presentation to drive reforms and investment in Australia's health future, focusing on clinical trials.

The new ALLG MDSO5 MESSAGE trial is exploring new treatment options for transfusion dependent MDS.

Discover the key highlights from ALLG's 2025 Annual Review, including our impact & research milestones.

Read about the highlights from ALLG's Nov Scientific Meeting.

Join the 2026 Sydney Marathon & run for ALLG.

We are pleased to announce Dr Safia Belbachir as our new Clinical Trials Fellow.

ALLG is proud showcase the cutting-edge research of our members at Blood 2025.

Read about how ALLG's Scientific Meetings help foster collaboration - sharing the latest advances in blood cancer research.

As Blood Cancer Awareness Month concludes, ALLG CEO, Delaine Smith, shares key research highlights.

Read about ALLG, and discover who we are and our impactful blood cancer research.

Read about how ALLG's CML SA Teams pioneered CML targeted therapies.

Clinical trials drive progress and advance future blood cancer treatments.

On World Cancer Research Day, Belinda shares her mum's Ania's AMLM26 INTERCEPT trial experience.

On World Patient Safety Day, ALLG reflects on the vital role of our Safety & Data Monitoring Committee and the patient voice.

The BM12 CAST Trial gave Stephanie life-saving treatment.

Support ALLG's clinical trial research & Go Red4Research to deliver Better treatments...Better lives.

CLL12 AETHER delivering new treatments to Australian patients.

ALLG are saddened to announce that our respected colleague and friend respected colleague and friend Dr Nicholas Murphy passed away on 30 July 2025 from recurrent brain cancer.

Discover how ALLG is revolutionising blood cancer treatment with BM12 & advancing transplant practices in Edition 12.